These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9286178)

  • 41. No D2 receptor increase in PET study of schizophrenia.
    Farde L; Wiesel FA; Hall H; Halldin C; Stone-Elander S; Sedvall G
    Arch Gen Psychiatry; 1987 Jul; 44(7):671-2. PubMed ID: 2955770
    [No Abstract]   [Full Text] [Related]  

  • 42. D4 receptors and schizophrenia.
    Strange PG; Vile JM
    J Neurochem; 1995 Nov; 65(5):2381-3. PubMed ID: 7595530
    [No Abstract]   [Full Text] [Related]  

  • 43. Maps of receptor binding parameters in the human brain--a kinetic analysis of PET measurements.
    Blomqvist G; Pauli S; Farde L; Eriksson L; Persson A; Halldin C
    Eur J Nucl Med; 1990; 16(4-6):257-65. PubMed ID: 2112470
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Brain dopamine receptors in schizophrenia: PET problems.
    Seeman P
    Arch Gen Psychiatry; 1988 Jun; 45(6):598-600. PubMed ID: 3259865
    [No Abstract]   [Full Text] [Related]  

  • 45. Positron emission tomography of brain dopamine D-2 receptors with 11C-raclopride in early Parkinson's disease.
    Laihinen A; Rinne JO; Någren K; Bergman J; Haaparanta M; Solin O; Ruotsalainen U; Rinne UK
    Acta Radiol Suppl; 1991; 376():151. PubMed ID: 1666759
    [No Abstract]   [Full Text] [Related]  

  • 46. Social dominance in female monkeys: dopamine receptor function and cocaine reinforcement.
    Nader MA; Nader SH; Czoty PW; Riddick NV; Gage HD; Gould RW; Blaylock BL; Kaplan JR; Garg PK; Davies HM; Morton D; Garg S; Reboussin BA
    Biol Psychiatry; 2012 Sep; 72(5):414-21. PubMed ID: 22503110
    [TBL] [Abstract][Full Text] [Related]  

  • 47. PET studies of dopamine receptors in relation to antipsychotic drug treatment.
    Farde L; Nordström AL; Halldin C; Wiesel FA; Sedvall G
    Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():468A-469A. PubMed ID: 1354052
    [No Abstract]   [Full Text] [Related]  

  • 48. Neurotransmitter receptor imaging in Alzheimer's disease.
    Sedvall G; Nybäck H; Farde L; Persson A
    J Neural Transm Suppl; 1987; 24():43-8. PubMed ID: 2824693
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of blood flow on [11C]raclopride binding in the brain: model simulations and kinetic analysis of PET data.
    Logan J; Volkow ND; Fowler JS; Wang GJ; Dewey SL; MacGregor R; Schlyer D; Gatley SJ; Pappas N; King P
    J Cereb Blood Flow Metab; 1994 Nov; 14(6):995-1010. PubMed ID: 7929663
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long-term stability of neurotransmitter activity investigated with 11C-raclopride PET.
    Schlösser R; Brodie JD; Dewey SL; Alexoff D; Wang GJ; Fowler JS; Volkow N; Logan J; Wolf AP
    Synapse; 1998 Jan; 28(1):66-70. PubMed ID: 9414019
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Use of positron emission tomography to study the dynamics of psychostimulant-induced dopamine release.
    Mach RH; Nader MA; Ehrenkaufer RL; Line SW; Smith CR; Gage HD; Morton TE
    Pharmacol Biochem Behav; 1997 Jul; 57(3):477-86. PubMed ID: 9218272
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Imaging of dopamine receptors using PET and SPECT.
    Hall H; Farde L; Halldin C; Högberg T; Larsson S; Sedvall G
    Neurochem Int; 1992 Mar; 20 Suppl():329S-333S. PubMed ID: 1365450
    [No Abstract]   [Full Text] [Related]  

  • 53. Sensitivity to subjective effects of cocaine in drug abusers: relationship to cerebral ventricle size.
    Morgan MJ; Cascella NG; Stapleton JM; Phillips RL; Yung BC; Wong DF; Shaya EK; London ED
    Am J Psychiatry; 1993 Nov; 150(11):1712-7. PubMed ID: 8214181
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The potential of positron-emission tomography for pharmacokinetic and pharmacodynamic studies of neuroleptics.
    Farde L; Wiesel FA; Nilsson L; Sedvall G
    Psychopharmacol Ser; 1989; 7():32-9. PubMed ID: 2574454
    [No Abstract]   [Full Text] [Related]  

  • 55. Cocaine reward and dopamine receptors: love at first site.
    Koob GF
    Arch Gen Psychiatry; 1999 Dec; 56(12):1107-8. PubMed ID: 10591287
    [No Abstract]   [Full Text] [Related]  

  • 56. Imaging the dopamine system with in vivo [11C]raclopride displacement studies: understanding the true mechanism.
    Ginovart N
    Mol Imaging Biol; 2005; 7(1):45-52. PubMed ID: 15912275
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacological approaches to cocaine addiction.
    Dackis CA; Gold MS
    J Subst Abuse Treat; 1985; 2(3):139-45. PubMed ID: 3912517
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Drug-induced receptor occupancy: substantial differences in measurements made in vivo vs ex vivo.
    Kapur S; Barlow K; VanderSpek SC; Javanmard M; Nobrega JN
    Psychopharmacology (Berl); 2001 Sep; 157(2):168-71. PubMed ID: 11594441
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Assessing neuroreceptor occupancy by continuous infusion of carbon-11 labeled radioligands.
    Kao PF; Kim S; Wagner HN; Lever JR; Ravert HT; Dannals RF
    Eur J Nucl Med; 1996 Feb; 23(2):141-4. PubMed ID: 8925847
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ibogaine and cocaine abuse: pharmacological interactions at dopamine and serotonin receptors.
    Sershen H; Hashim A; Lajtha A
    Brain Res Bull; 1997; 42(3):161-8. PubMed ID: 8995326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.